Clinical stage I non-small cell lung cancer including FDG-PET imaging: Sites and time to recurrence

Journal of Thoracic Oncology

Volumn 2, Issue 6, 2007, Pages 499-505

  Gauger, Joerg ^a   Patz Jr , Edward F ^a   Coleman, R Edward ^a   Herndon II, James E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Imaging; Lung cancer; Positron emission tomography; Recurrence; Staging

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADRENAL GLAND; ADULT; AGED; ARTICLE; BONE; BRAIN; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIMAL DRUG DOSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; THORAX; CANCER STAGING; LUNG TUMOR; MIDDLE AGED; SCINTISCANNING; SURVIVAL RATE; TIME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 34447120170     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3180600990     Document Type: Article

References (18)

1. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123:137S-146S.
2. Hicks RJ, Kalff V, MacManus MP, et al. 18FDG-PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 2001;42(11):1596-1604.
3. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s meta-analytic comparison of PET and CT. Radiology 1999;213:530-536.
4. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
5. van Rens MTM, del la Rivière AB, Elbers HRJ van den Bosch JMM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-379.
6. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for brochogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-1764.
7. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-1057.
8. Ahuja V, Coleman RE, Herndon JH, Patz EF. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918-924.
9. Vansteenkiste J, Fischer BM, Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 2004;5:531-540.
10. Cheran SC, Nielsen ND, Patz EF. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol 2004;182:1129-1132.
11. Hotta K, Sekine I, Suzuki K, et al. Distant failure after treatment of postoperative locoregional recurrence of non-small cell lung cancer. Thorac Cardiovasc Surg 2003;51:283-287.
12. Westeel V, Choma D, Clement F, et al. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 2000;70:1185-1190.
13. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
14. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507.
15. Ludwig Lung Cancer Study Group. Patterns of failure in patient with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 1987;205:67-71.
16. Iascone C, DeMeester TR, Albertucci M, Little AG, Golomb HM. Local recurrence of respectable non-small cell carcinoma of the lung. Cancer 1986;57:471-476.
17. Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002;123:280-287.
18. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-827.